Development of CAR-T cells specifically targeting cancer stem cell antigen DNAJB8 against solid tumours.
Yuto WatanabeTomohide TsukaharaKenji MurataShuto HamadaTerufumi KuboTakayuki KanasekiYoshihiko HirohashiMakoto EmoriAtsushi TeramotoMunehide NakatsugawaToshihiko YamashitaToshihiko TorigoePublished in: British journal of cancer (2022)
B10 CAR-T cells could show specific cytotoxicity against RCC and osteosarcoma cells in vitro and in vivo. B10 CAR-T cells targeting the CSC/CIC antigen DNAJB8 might be a candidate immunotherapy for carcinoma and sarcoma.